Researchers have shown that the amount of a protein called CD74 can indicate which people with bowel cancer may respond best to immunotherapy. If integrated into...
British techbio company Etcembly is teaming up with researchers and clinicians from the University of Surrey to launch a new study aimed at transforming the future...
Results from a large clinical trial show that treatment with an immunotherapy drug may nearly double the length of time people with high-risk, muscle-invasive bladder cancer...
A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved lung cancer survival rates, according to a new study. This was compared to...
